Browse > Article

Probiotic Property of Lactobacillus pentosus Miny-148 Isolated from Human Feces  

Jung, Min-Young (Biological Resource Center, KRIBB)
Park, Yong-Ha (Department of Applied Microbiology, Yeungnam University)
Kim, Hyun-Soo (College of Veterinay Medicine, Chungnam National University)
Poo, Ha-Ryoung (Biological Resource Center, KRIBB)
Chang, Young-Hyo (Biological Resource Center, KRIBB)
Publication Information
Korean Journal of Microbiology / v.45, no.2, 2009 , pp. 177-184 More about this Journal
Abstract
Three hundred lactic acid bacteria isolated from human feces were studied their probiotic characters to develop potential probiotics. The properties were tested on the basis of guideline for probiotic selection protocol such as tolerance for acid or bile salt, thermal stability, antimicrobial, anticancer cell, and antiviral activity. Strain Miny-148 was selected as a potential probiotic bacterium which showed resistance to low pH, bile salts and thermal stability. On the basis of fatty acid profiles and 16S rDNA sequences analysis, the strain was identified as Lactobacillus pentosus (similarity 99.9%). The strain, L. pentosus Miny-148, showed broad antimicrobial spectrum against E. coli O157:H7, Shigella flexneri, Bacillus anthracis, Staphylococcus aureus, E. coli, Vibrio cholerae, V. vulnificus, Salmonella typhimurium, and Methicillin-resistant S. aureus (MRSA). Cell-free culture supernatant of the strain also inhibited against the growth of HT-29 colon cancer cell and transmissible gastroenterits virus.
Keywords
antimicrobial; identification; Lactobacillus; pathogenic; probiotic;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Baricault, L., G. Denariaz, J.J. Houri, C. Bouley, C. Sapin, and G. Trugnan. 1995. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16, 245-252   DOI   ScienceOn
2 Byun, J.W., G.T. Kim, H.S. Bae, Y.J. Baek, and Y.K. Lee. 2000. In vitro selection of lactic acid bacteria for probiotic use in pigs. Korea J. Vet. Res. 40, 701-706
3 Cho, M.K., K. Kim, C.H. Kim, T.K. Lee, and K.Y. Kim. 2000. Isolation and characterization of Lactobacillus fermentum YL-3 as a poultry probiotic. Kor. J. Appl. Microbiol. Biotechnol. 28, 279-284   과학기술학회마을
4 Gram, L., J. Melchiorsen, B. Spanggaard, I. Huber, and T.F. Nielsen. 1999. Inhibition of Vibrio anguillarum by Pseudomonas fluorescens AH2, a possible probiotic treatment of fish. Appl. Environ. Microbiol. 65, 969-973   PUBMED   ScienceOn
5 Ha, C.G., J.K. Cho, Y.K. Chai, and K.C. Heo. 2004. Isolation and identification of lactic bacteria containing superior activity of the bile salts deconjugation. Kor. J. Food Sci. Ani. Resour. 24, 164-170   과학기술학회마을   ScienceOn
6 Kim, Y.G., J.T. Moon, K.M. Lee, N.R. Chon, and H. Park. 2006. The effects of probiotics on symptoms of irritable bowel syndrome. Korean J. Gastroenterol. 47, 413-419   PUBMED
7 Reed, M.J. and M. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hygiene 27, 493-497
8 Rosenfeldt, V., E. Benfeldt, S.D. Nielsen, K.F. Michaelsen, D.L. Jeppesen, N.H. Valerius, and A. Paerregaard. 2003. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111, 389-395   DOI   ScienceOn
9 Shin, M.S., H.M. Kim, G.T. Kim, C.S. Huh, H.S. Bae, and Y.J. Baek. 1999. Selection and characteristics of Lactobacillus acidophilus isolated from Korean feces. Kor. J. Food Sci. Technol. 31, 495-501   과학기술학회마을   ScienceOn
10 Bezkorovainy, A. 2001. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73, 399S-405S   DOI   PUBMED
11 Shah, G.D., J.S. Silver, S.S. Rosenfeld, I.T. Gavrilovic, L.E. Abrey, and A.B. Lassman. 2007. Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas. J. Neurooncol. 85, 217-222   DOI   ScienceOn
12 Chang, Y.H., J.K. Kim, H.J. Kim, W.Y. Kim, Y.B. Kim, and Y.H. Park. 2001. Selection of a potential probiotic Lactobacillus strain and subsequent in vivo studies. Antonie Van Leeuwenhoek 80, 193-199   DOI   ScienceOn
13 Berg, R.D. 1998. Probiotics, prebiotics or conbiotics. Trends Microbiol. 6, 89-92   DOI   PUBMED   ScienceOn
14 Ringel-Kulka, T. and Y. Ringel. 2007. Probiotics in irritable bowel syndrome: has the time arrived? Gastroenterology 132, 813-816   DOI   ScienceOn
15 Sartor, R.B. 2001. Intestinal microflora in human and experimental inflammatory bowel disease. Curr. Opin. Gastroenterol. 17, 324-330   DOI   PUBMED   ScienceOn
16 Casey, P.G., G.D. Casey, G.E. Gardiner, M. Tangney, C. Stanton, R.P. Ross, C. Hill, and G.F. Fitzgerald. 2004. Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tract. Lett. Appl. Microbiol. 39, 431-438   DOI   ScienceOn
17 Saggioro, A. 2004. Probiotics in the treatment of irritable bowel syndrome. J. Clin. Gastroenterol. 38(6 Suppl), S104-106   DOI   ScienceOn
18 Weese, J.S., M.E. Anderson, A. Lowe, R. Penno, T.M. da Costa, L. Button, and K.C. Goth. 2004. Screening of the equine intestinal microflora for potential probiotic organisms. Equine Vet. J. 36, 351-355   DOI   ScienceOn
19 Kim, K., K.L. Jang, C.H. Kim, and K.Y. Kim. 2002. Optimization of culture conditions and encapsulation of Lactobacillus fermentum YL-3 for probiotics. Kor. J. Food Sci. Technol. 34, 255-262   과학기술학회마을   ScienceOn
20 Chang, Y.H., J.K. Kim, H.J. Kim, J.H. Yoon, W.Y. Kim, Y.W. Choi, W.J. Lee, Y.B. Kim, and Y.H. Park. 1999. Characteristics of Lactobacillus reuterii BSA -131 isolated from swine intestine. Kor. J. Appl. Microbiol. Biotechnol. 27, 23-27   과학기술학회마을
21 Kim, P.I., M.Y. Jung, Y.H. Chang, S. Kim, S.J. Kim, and Y.H. Park. 2007. Probiotic properties of Lactobacillus and Bifidobacterium strains isolated from porcine gastrointestinal tract. Appl. Microbiol. Biotechnol. 74, 1103-1111   DOI   ScienceOn
22 Foligne, B., S. Nutten, C. Grangette, V. Dennin, D. Goudercourt, S. Poiret, J. Dewulf, D. Brassart, A. Mercenier, and B. Pot. 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 13, 236-243   DOI   PUBMED
23 O'Sullivan, M.A. and C.A. O'Morain. 2000. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig. Liver Dis. 32, 294-301   DOI   ScienceOn
24 Sartor, R.B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577-594   DOI   PUBMED   ScienceOn
25 Lee, E.Y. 2008. Problems and verification system of probiotics as livestock-environment improving agent produced and circulated. Kor. J. Microbiol. Biotechnol. 36, 87-95   과학기술학회마을
26 Ringel, Y., A.D. Sperber, and D.A. Drossman. 2001. Irritable bowel syndrome. Annu. Rev. Med. 52, 319-338   DOI   ScienceOn
27 Koga, T., T. Mizobe, and K. Takumi. 1998. Antibacterial activity of Lactobacillus species against Vibrio species. Microbiol. Res. 153, 271-275   DOI   PUBMED   ScienceOn
28 Gallagher, T.M. and M.J. Buchmeier. 2001. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279, 371-374   DOI   ScienceOn
29 Sinn, D.H., J.H. Song, H.J. Kim, J.H. Lee, H.J. Son, D.K. Chang, Y.H. Kim, J.J. Kim, J.C. Rhee, and P.L. Rhee. 2008. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig. Dis. Sci. 53, 2714-2718   DOI   ScienceOn